Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Structural Brain Changes in Graves’ Hyperthyroidism may be of Autoimmune Origin
source: Thyroid
year: 2018
authors: M. Holmberg, K. Tammelin , P.F. Berglund , L. Bunketorp-Ka¨ll , R. Heckemann, B. Johansson , N. Klasson, A. Lundgren, E. Olsson, S. Skau, H. Malmgren, H. Filipsson Nystrom
summary/abstract:In Graves’ disease (GD), brain-derived symptoms are prevalent. During the hyperthyroid state, the volumes of medial temporal lobe (MTL) structures, e.g. the hippocampi, are reduced. This has been attributed to the high thyroid hormone levels, but we hypothesize that the structural changes and mental symptoms may be due to autoimmunity per se.
Here, autoimmunity directly related to the thyroid as well as other autoimmunity may be important. The aim of the present paper was to determine the relations between non-thyroid autoimmunity and MTL volumes during hyperthyroidism in GD. The CogThy project is a longitudinal observational prospective casecontrol study where 65 premenopausal women were evaluated within 2 weeks after the diagnosis of GD with FT4 > 50 pmol/L (reference 12-22) and after 15 months of anti-thyroid treatment. Thyroidstimulating hormone receptor antibodies (TRAb), thyroid stimulating immunoglobulins (TSI), angiotensin II type 1- (anti-AT1), beta 1 adrenergic- (anti-B1) and M2 muscarinic- (anti-M2) receptor antibodies were measured in the hyperthyroid state. MTL structures were assessed with a 3-Tesla MR scanner to determine hippocampal and amygdala volumes using automatic segmentation with MAPER and normalisation to intracranial volume.
organization: University of Gothenburg, Sweden; Karolinska University Hospital, Sweden; Sahlgrenska University Hospital, Senegal; Sahlgrenska University Hospital, Sweden; University of Gothenburg, Swedenread more
Related Content
-
Predicting Risk of Recurrent Thyrotoxicosis Following Thionamide Withdrawal in Graves’ DiseaseBackground/Aim: Thionamides are a safe ...
-
Conversion to Graves’ Disease from Hashimoto Thyroiditis: A Study of 24 patientsObjective: The conversion of Hashimoto'...
-
Michael S. Lee, MDMichael S. Lee is a Director of Neuro-Op...
-
Recent Developments in Graves’ OphthalmopathyRecent Developments in Graves' ophthalmo...
-
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With HyperthyroidismImportance Radioactive iodine (RAI) h...
-
Radioiodine Therapy for HyperthyroidismA 37-year-old woman receives a diagnosis...
-
Treatment of Graves’ Disease – An OverviewHyperthyroidism may be defined as the ex...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
myBinder